Cytokinetics, Incorporated · NASDAQ:CYTK

Wierenga Wendell received 95 Cytokinetics, Incorporated shares as an award (Form 4)

Traded Apr 15, 2026 · Filed Apr 15, 2026

On Apr 15, 2026, Wierenga Wendell (Director) received 95 Cytokinetics, Incorporated shares as an award at US$65.37 for US$6,210, leaving 32,637 shares. Filed Apr 15, 2026 (Form 4).

Awarded
95 shares
Price
US$65.37
Value
US$6,210
Holding after
32,637 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 15, 2026Common StockAward95US$65.3732,637Direct

Source

View original at SEC

Related